What is the recommended permethrin and ivermectin regimen for treating scabies in a healthy adult?

Treatment of Scabies with Permethrin and Ivermectin

For healthy adults with scabies, use permethrin 5% cream applied to the entire body from neck down for 8-14 hours as first-line treatment, or alternatively oral ivermectin 200 µg/kg repeated in 2 weeks, with permethrin being more effective, safer, and less expensive. 1

First-Line Treatment Regimens

Permethrin 5% Cream (Preferred)

• Apply to all areas of the body from the neck down and wash off after 8-14 hours 1, 2
• Usually 30 grams is sufficient for an average adult 2
• One application is generally curative, though the regimen should be repeated after 7-10 days 1, 2
• More effective than ivermectin with cure rates of 88.5-96.9% versus 62.4-71.8% for single-dose ivermectin 3, 4
• Less expensive than ivermectin and has a more rapid onset of action 1, 5

Oral Ivermectin (Alternative)

• 200 µg/kg orally, repeated in 2 weeks (day 0 and day 14) 1
• Must be taken with food to increase bioavailability and epidermal penetration 1
• The second dose is critical because ivermectin has limited ovicidal activity and cannot prevent hatching of eggs present at initial treatment 1
• Single-dose regimens have significantly lower cure rates (58-62.4%) compared to two-dose regimens (89.7-92.8%) 6, 4, 5
• Absence of the second dose is a major predictor of treatment failure 6, 7

Comparative Efficacy Evidence

The most recent high-quality evidence demonstrates permethrin superiority:

• A 2026 cluster randomized trial of 1,075 participants showed permethrin achieved 88.5% cure rates versus 71.8% for ivermectin at the household level 3
• Individual cure rates were 91.5% for permethrin versus 76.6% for ivermectin 3
• Permethrin-treated patients recovered earlier with faster resolution of pruritus 4, 5
• Both treatments are equally well-tolerated, with cutaneous adverse events in 11.9% (ivermectin) versus 15.6% (permethrin) 3

Critical Management Considerations

Application Technique for Permethrin

• Apply thoroughly to entire body surface from neck down 1, 2
• In infants and elderly patients, also treat the scalp, hairline, neck, temple, and forehead 1, 2
• Some evidence suggests applying cold cream (stored in refrigerator) once daily for two consecutive days may be more effective than single application (87.2% vs 61.8% cure rate) 8

Dosing Adjustments

• No renal dose adjustment needed for ivermectin 1
• Safety of multiple ivermectin doses in severe liver disease is unknown 1
• One study showed increased mortality in elderly, debilitated persons receiving ivermectin, though not confirmed in subsequent reports 1

Environmental Decontamination (Essential)

• Machine-wash and machine-dry bedding and clothing using hot cycle, or dry clean 1
• Alternatively, remove items from body contact for at least 72 hours 1
• Fumigation of living areas is unnecessary 1
• Intensified decontamination measures (storing clothes in plastic bags for 4 days, vacuum cleaning car seats) are associated with treatment success 7

Common Pitfalls and How to Avoid Them

Post-Treatment Pruritus

• Pruritus may persist for up to 2 weeks after successful treatment 1
• This is rarely a sign of treatment failure and is NOT an indication for retreatment 2
• Approximately 75% of patients with persistent pruritus at 2 weeks had resolution by 4 weeks 2
• Only retreat if demonstrable living mites are found after 14 days 2

Treatment Failure Risk Factors

• Permethrin monotherapy without repeat application is associated with failure 7
• Single-dose ivermectin without the critical second dose at 2 weeks 6, 7
• Inadequate environmental decontamination 7
• Failure to treat household contacts simultaneously 1

Contact Management

• All household members and close contacts within the preceding month must be examined and treated simultaneously 1
• Sexual contact should be avoided until both patients and partners are treated and reevaluated 1

Special Populations

Pregnancy and Lactation

• Permethrin is safe during pregnancy and lactation 1
• Ivermectin is classified as "human data suggest low risk" in pregnancy and probably compatible with breastfeeding 1
• Lindane should be avoided (associated with neural tube defects and mental retardation) 1

Children

• Infants and young children should be treated with permethrin 1
• Permethrin is safe in children ≥2 months of age 2
• Ivermectin safety is established in children >15 kg 9
• Children <10 years should not receive lindane 1

HIV/Immunocompromised Patients

• Receive the same treatment regimen as immunocompetent patients for uncomplicated scabies 1
• Higher risk for crusted (Norwegian) scabies requiring more aggressive combination therapy 1